Cargando…

Growth Pattern in Chinese Children With 5α-Reductase Type 2 Deficiency: A Retrospective Multicenter Study

BACKGROUND: 5α-reductase type 2 deficiency (5αRD) is an autosomal recessive hereditary disease of the group of 46, XY disorders of sex development (DSD). OBJECTIVE: To study the growth pattern in Chinese pediatric patients with 5αRD. SUBJECTS: Data were obtained from 141 patients with 5αRD (age: 0–1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xiu, Song, Yanning, Chen, Shaoke, Wang, Xiumin, Luo, Feihong, Yang, Yu, Chen, Linqi, Chen, Ruimin, Chen, Hui, Su, Zhe, Wu, Di, Gong, Chunxiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429988/ https://www.ncbi.nlm.nih.gov/pubmed/30930770 http://dx.doi.org/10.3389/fphar.2019.00173

Ejemplares similares

Growth Curves of Chinese Children with Androgen Insensitivity Syndrome: A Multicenter Registry Study
por: Zhao, Xiu, et al.
Publicado: (2022)

Clinical characteristics and genotype‐phenotype correlations of 130 Chinese children in a high‐homogeneity single‐center cohort with 5α‐reductase 2 deficiency
por: Fan, Lijun, et al.
Publicado: (2020)

Phenotype and Molecular Characterizations of 30 Children From China With NR5A1 Mutations
por: Song, Yanning, et al.
Publicado: (2018)

Exploring the efficacy of testosterone undecanoate in male children with 5α‐reductase deficiency
por: Liu, Ying, et al.
Publicado: (2021)

Polyethylene glycol recombinant human growth hormone in Chinese prepubertal slow-growing short children: doses reported in a multicenter real-world study
por: Chen, Jiajia, et al.
Publicado: (2022)

Bioactives in Chinese Proprietary Medicine Modulates 5α-Reductase Activity and Gene Expression Associated with Androgenetic Alopecia
por: Tan, Justin J. Y., et al.
Publicado: (2017)

A Multicenter Survey of Type I Diabetes Mellitus in Chinese Children
por: Hou, Ling, et al.
Publicado: (2021)

Regulation of Aldo–Keto Reductases in Human Diseases
por: Chen, Wei-Dong, et al.
Publicado: (2012)

Identification of Characteristic Autoantibodies Associated With Deficiency Pattern in Traditional Chinese Medicine of Rheumatoid Arthritis Using Protein Chips
por: Zhao, Heru, et al.
Publicado: (2019)

Construction of a new complete growth reference for urban Chinese children
por: Wu, Wei, et al.
Publicado: (2022)

Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
por: Poirier, Andrée-Anne, et al.
Publicado: (2022)

Novel phenotypes and genotypes in Antley-Bixler syndrome caused by cytochrome P450 oxidoreductase deficiency: based on the first cohort of Chinese children
por: Fan, Lijun, et al.
Publicado: (2019)

Chinese childrens’ diabetes status, trends and hardship
por: Fu, Junfen, et al.
Publicado: (2013)

Genetic Analysis of 25 Patients with 5α-Reductase Deficiency in Chinese Population
por: Han, Bing, et al.
Publicado: (2020)

The Effects of Genetic Variation in FTO rs9939609 on Obesity and Dietary Preferences in Chinese Han Children and Adolescents
por: Yang, Min, et al.
Publicado: (2014)

U-shaped relationship between birth weight and childhood blood pressure in China
por: Lai, Chong, et al.
Publicado: (2019)

Ficus benghalensis as Potential Inhibitor of 5α-Reductase for Hair Growth Promotion: In Vitro, In Silico, and In Vivo Evaluation
por: Iltaf, Jawaria, et al.
Publicado: (2021)

The Effect of Chinese Medicine Compound in the Treatment of Rheumatoid Arthritis on the Level of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibodies: A Systematic Review and Meta-Analysis
por: Tang, Xuan, et al.
Publicado: (2021)

Reasons and Factors Contributing to Chinese Patients’ Preference for Ustekinumab in Crohn’s Disease: A Multicenter Cross-Sectional Study
por: Yao, Lingya, et al.
Publicado: (2021)

Chinese Herbal Medicine Combined With EGFR-TKI in EGFR Mutation-Positive Advanced Pulmonary Adenocarcinoma (CATLA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Jiao, Lijing, et al.
Publicado: (2019)

α1-Blockers and 5α-Reductase Inhibitors Are the Most Recommended Drugs in Treating Benign Prostatic Hyperplasia: An Evidence-Based Evaluation of Clinical Practice Guidelines
por: Xu, Xiao-Feng, et al.
Publicado: (2020)

Corticosteroid Use in the Treatment of COVID-19: A Multicenter Retrospective Study in Hunan, China
por: Ma, Yiming, et al.
Publicado: (2020)

PSORS1C1 Hypomethylation Is Associated with Allopurinol-Induced Severe Cutaneous Adverse Reactions during Disease Onset Period: A Multicenter Retrospective Case-Control Clinical Study in Han Chinese
por: Sun, Bao, et al.
Publicado: (2018)

Maintenance Chemotherapy With Chinese Herb Medicine Formulas vs. With Placebo in Patients With Advanced Non-small Cell Lung Cancer After First-Line Chemotherapy: A Multicenter, Randomized, Double-Blind Trial
por: Wang, Qin, et al.
Publicado: (2018)

Preterm Birth and Birth Weight and the Risk of Type 1 Diabetes in Chinese Children
por: Huang, Ke, et al.
Publicado: (2021)

Identification of three novel SRD5A2 mutations in Chinese patients with 5α-reductase 2 deficiency
por: Cheng, Tong, et al.
Publicado: (2019)

Aldose Reductase, Oxidative Stress, and Diabetic Mellitus
por: Tang, Wai Ho, et al.
Publicado: (2012)

Biliverdin reductase: a target for cancer therapy?
por: Gibbs, Peter E. M., et al.
Publicado: (2015)

Utilization patterns and prescription characteristics of traditional Chinese medicine among patients with irritable bowel syndrome in Taiwan
por: Gu, Ye, et al.
Publicado: (2023)

Traditional Chinese Medicine Injections Combined With Antihypertensive Drugs for Hypertensive Nephropathy: A Network Meta-Analysis
por: Chen, Zhe, et al.
Publicado: (2021)

Cost-Effectiveness of Alirocumab for the Secondary Prevention of Cardiovascular Events after Myocardial Infarction in the Chinese Setting
por: Liang, Zhe, et al.
Publicado: (2021)

Activation of α7nAChR Protects Against Gastric Inflammation and Dysmotility in Parkinson’s Disease Rats
por: Zhou, Li, et al.
Publicado: (2021)

Go Green: The Anti-Inflammatory Effects of Biliverdin Reductase
por: Wegiel, Barbara, et al.
Publicado: (2012)

Aldo-Keto Reductases 1B in Endocrinology and Metabolism
por: Pastel, Emilie, et al.
Publicado: (2012)

Biliverdin Reductase: More than a Namesake – The Reductase, Its Peptide Fragments, and Biliverdin Regulate Activity of the Three Classes of Protein Kinase C
por: Gibbs, Peter E. M., et al.
Publicado: (2012)

Traditional Chinese Medicine Injections Combined With Oseltamivir for Influenza: Systematic Review and Network Meta-Analysis
por: Peng, Yingying, et al.
Publicado: (2022)

Traditional Chinese Medicine Qingre Huoxue Treatment vs. the Combination of Methotrexate and Hydroxychloroquine for Active Rheumatoid Arthritis: A Multicenter, Double-Blind, Randomized Controlled Trial
por: Gong, Xun, et al.
Publicado: (2021)

Nanoformulation improves antitumor efficacy of MAOI immune checkpoint blockade therapy without causing aggression-related side effects
por: Brown, James, et al.
Publicado: (2022)

Role of Aldo–Keto Reductase Enzymes in Mediating the Timing of Parturition
por: Byrns, Michael C.
Publicado: (2012)

Peripheralized sepiapterin reductase inhibition as a safe analgesic therapy
por: Cronin, Shane J. F., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0c3eiivfsbhmfq6b86pco8pbeg